• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec4
Ionis Pharmaceuticals Director Sold Company Common Stock
00:01
Dec1
Ionis Pharmaceuticals Receives FDA Breakthrough Therapy Designation
12:01
Nov28
Ionis Pharmaceuticals Director Disposes of Company Common Stock
22:52
Ionis Pharmaceuticals EVP and CHRO Shannon L. Devers Sells Common Stock
22:52
Nov17
Ionis Pharmaceuticals Announces $700 Million Convertible Senior Notes Offering
21:07
Ionis Pharmaceuticals' DAWNZERA Recommended for Approval in Europe
06:49

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 156.72 M, Net Income -128.61 M, EPS -0.8049

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 452.05 M, Net Income 123.55 M, EPS 0.7

Apr30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 131.61 M, Net Income -146.94 M, EPS -0.9256

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.160
+198.31%
+12.968
SMX
301.230
+113.64%
+160.230
WHLR
5.780
+78.40%
+2.528
GURE
8.051
+69.85%
+3.311
DBRG
14.100
+45.06%
+4.300
IRBT
4.320
+42.57%
+1.300
TORO
5.420
+31.23%
+1.290
SPHL
4.331
+30.05%
+1.001
TDIC
0.3649
+29.95%
+0.084
PRAX
246.435
+29.72%
+56.465
View More